The use of ketamine is considered “on-label” when it is used for medical purposes that the FDA has approved it for. When it is used for other conditions that are not covered by the FDA designation, then the use is considered “off-label”.
Psychedelic therapy for anxiety and depression is a hot topic these days. You may have heard about it on Michael Pollan’s recent Netflix series, How to Change Your Mind. The series devotes each episode to a different psychedelic medicine including LSD, psilocybin, MDMA and mescaline. These four drugs all have their own benefits and drawbacks, similarly to ketamine. Let’s take a look at each drug’s legal status, safety concerns and indicated uses.
Ketamine can provide similar psychedelic effects to other drugs such as LSD, MDMA, psilocybin and mescaline and is used to treat some of the same mood disorders. What exactly is a psychedelic?
The brain relies on specialized chemicals called neurotransmitters to communicate with the nervous system and body. Different neurotransmitters are involved in a wide array of functions, depending on which neural circuits they act on.
Ketamine is a powerful drug capable of profoundly affecting your mind and body. It has different effects at different doses.
In early 2019, an esketamine nasal spray was approved by the FDA for adults with treatment-resistant depression. Its FDA-approved uses were later expanded to include patients suffering from acute suicidal ideation. But what is esketamine, and how is it different from regular ketamine?
What really goes on in the brain when a patient undergoes ketamine therapy? Read on to find out.